Cargando…
DNA Methylation-Guided Prediction of Clinical Failure in High-Risk Prostate Cancer
BACKGROUND: Prostate cancer (PCa) is a very heterogeneous disease with respect to clinical outcome. This study explored differential DNA methylation in a priori selected genes to diagnose PCa and predict clinical failure (CF) in high-risk patients. METHODS: A quantitative multiplex, methylation-spec...
Autores principales: | Litovkin, Kirill, Van Eynde, Aleyde, Joniau, Steven, Lerut, Evelyne, Laenen, Annouschka, Gevaert, Thomas, Gevaert, Olivier, Spahn, Martin, Kneitz, Burkhard, Gramme, Pierre, Helleputte, Thibault, Isebaert, Sofie, Haustermans, Karin, Bollen, Mathieu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4472347/ https://www.ncbi.nlm.nih.gov/pubmed/26086362 http://dx.doi.org/10.1371/journal.pone.0130651 |
Ejemplares similares
-
MiR-205 Is Progressively Down-Regulated in Lymph Node Metastasis but Fails as a Prognostic Biomarker in High-Risk Prostate Cancer
por: Kalogirou, Charis, et al.
Publicado: (2013) -
Hedgehog Signaling in Prostate Cancer and Its Therapeutic Implication
por: Gonnissen, Annelies, et al.
Publicado: (2013) -
Targeting the Hedgehog signaling pathway in cancer: beyond Smoothened
por: Gonnissen, Annelies, et al.
Publicado: (2015) -
Neoadjuvant degarelix with or without apalutamide followed by radical prostatectomy for intermediate and high-risk prostate cancer: ARNEO, a randomized, double blind, placebo-controlled trial
por: Tosco, Lorenzo, et al.
Publicado: (2018) -
Potential Molecular Mechanisms behind the Ultra-High Dose Rate “FLASH” Effect
por: Bogaerts, Eva, et al.
Publicado: (2022)